Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
|
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [1] Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma
    Tegos, Theodoros
    Tegos, Konstantinos
    Dimitriadou, Areti
    Dimitriadis, Georgios
    JOURNAL OF BUON, 2019, 24 (04): : 1340 - 1353
  • [2] Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapies
    Zhang, Tian
    Zhu, Jason
    George, Daniel J.
    Nixon, Andrew B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) : 510 - 518
  • [3] Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma
    Serzan, Michael T.
    Atkins, Michael B.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [4] Current and Emerging First-Line Systemic Therapies in Clear Cell Renal Cell Carcinoma
    Rini, Brian I.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 115 - 117
  • [5] Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
    Atkins, Michael B.
    Tannir, Nizar M.
    CANCER TREATMENT REVIEWS, 2018, 70 : 127 - 137
  • [6] BIOMARKERS OF SUNITNIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA PATIENTS
    Bastien, L.
    Paule, B.
    Maille, P.
    Azoulay, S.
    Allory, Y.
    Patard, J. J.
    Rioux-Leclercq, N.
    Crepel, M.
    Wallerand, H.
    Bernhard, J. C.
    Game, X.
    Mazerolles, C.
    Guillotreau, J.
    Ruffion, A.
    Decaussin-Petrucci, M.
    Zini L.
    Leroy, X.
    Berthon, N.
    Culine, S.
    Salomon, L.
    Hoznek, A.
    Vordos, D.
    Abbou, C. C.
    Mourah, S.
    De La Taille, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 298 - 298
  • [7] Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
    Matrana, Marc R.
    Atkinson, Bradley
    Jonasch, Eric
    Tannir, Nizar M.
    CURRENT CLINICAL PHARMACOLOGY, 2011, 6 (03): : 189 - 198
  • [8] Update on systemic therapies of metastatic renal cell carcinoma
    E. Herrmann
    S. Bierer
    C. Wülfing
    World Journal of Urology, 2010, 28 : 303 - 309
  • [9] Update on systemic therapies of metastatic renal cell carcinoma
    Herrmann, E.
    Bierer, S.
    Wuelfing, C.
    WORLD JOURNAL OF UROLOGY, 2010, 28 (03) : 303 - 309
  • [10] Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
    Abah, Moses Owoicho
    Ogenyi, Deborah Oganya
    Zhilenkova, Angelina V.
    Essogmo, Freddy Elad
    Tchawe, Yvan Sinclair Ngaha
    Uchendu, Ikenna Kingsley
    Pascal, Akaye Madu
    Nikitina, Natalia M.
    Rusanov, Alexander S.
    Sanikovich, Varvara D.
    Pirogova, Yuliya N.
    Boroda, Alexander
    Moiseeva, Aleksandra V.
    Sekacheva, Marina I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
12345